Get started
Author

Thomas V. Jones

Observed names: Jones, Thomas, T Jones, T V Jones, T. Jones, T. V. Jones, T.V. Jones, THOMAS V. JONES, Thomas Jones, Thomas V Jones
OpenAlex ID: A5082474412
Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials
2018 · William J. Sandborn, Julián Panés, et al. · Clinical Gastroenterology and Hepatology · 248
Written case simulations: Do they predict physicians' behavior?
1990 · Thomas V. Jones, Martha S. Gerrity, et al. · Journal of Clinical Epidemiology · 233
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data
2020 · Philip Mease, Christina Charles-Schoeman, et al. · Annals of the Rheumatic Diseases · 218
PDF
Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis
2018 · Uma Mahadevan, Marla C Dubinsky, et al. · Inflammatory Bowel Diseases · 176
PDF
Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme
2019 · William J. Sandborn, Julian Panés, et al. · Alimentary Pharmacology & Therapeutics · 169
PDF
Performance of alcoholism screening questionnaires in elderly veterans
1996 · Joy L. Morton, Thomas V. Jones, et al. · The American Journal of Medicine · 110
Alcoholism screening questionnaires
1993 · Thomas V. Jones, Byron A. Lindsey, et al. · Journal of General Internal Medicine · 77
Efficacy and safety of tofacitinib in older and younger patients with rheumatoid arthritis.
2017 · Jeffrey R Curtis, Hendrik Schulze-Koops, et al. · PubMed · 70
Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivity
2016 · Josef S. Smolen, Vibeke Strand, et al. · Arthritis Research & Therapy · 69
PDF
Changes in Lipid Levels and Incidence of Cardiovascular Events Following Tofacitinib Treatment in Patients With Psoriatic Arthritis: A Pooled Analysis Across Phase III and Long‐Term Extension Studies
2019 · Dafna D. Gladman, Christina Charles‐Schoeman, et al. · Arthritis Care & Research · 58
PDF
Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposure
2021 · Gerd R Burmester, Peter Nash, et al. · RMD Open · 53
PDF
An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data
2020 · Gerd R. Burmester, Jeffrey R. Curtis, et al. · Drug Safety · 43
PDF
Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program
2022 · Gary R Lichtenstein, Brian Bressler, et al. · Inflammatory Bowel Diseases · 39
PDF
Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial
2018 · Josef S. Smolen, Annette Szumski, et al. · Arthritis Research & Therapy · 38
PDF
Worldwide post‐marketing safety surveillance experience with tofacitinib in ulcerative colitis
2021 · David T. Rubin, Irene Modesto, et al. · Alimentary Pharmacology & Therapeutics · 30
PDF
The Merck manual of health & aging
2012 · Mark H. Beers, Thomas V. Jones, et al. · Medical Entomology and Zoology · 22
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
2016 · Mark C. Genovese, Ronald F. van Vollenhoven, et al. · Arthritis Research & Therapy · 20
PDF
Approaches to Urinary Incontinence in a Rural Population: A Comparison of Physician Assistants, Nurse Practitioners, and Family Physicians
1998 · T. V. Jones, S. H. Bunner · The Journal of the American Board of Family Medicine · 19
PDF
904 - Tofacitinib for the Treatment of Ulcerative Colitis: Up to 4.4 Years of Safety Data from Global Clinical Trials
2018 · William J. Sandborn, Julian Panes, et al. · Gastroenterology · 13
S0847 Pregnancy Outcomes in the Tofacitinib Ulcerative Colitis OCTAVE Studies: An Update as of February 2020
2020 · Uma Mahadevan, Daniel C. Baumgart, et al. · The American Journal of Gastroenterology · 12
The impact of rheumatoid arthritis on work and predictors of overall work impairment from three therapeutic scenarios
2015 · Vibeke Strand, Thomas V Jones, et al. · International Journal of Clinical Rheumatology · 11
Recognition and Management of Oral Health Problems in Older Adults by Physicians: A Pilot Study
1998 · T. V. Jones, M. J. Siegel, et al. · The Journal of the American Board of Family Medicine · 11
PDF
Alcohol and injuries in elderly people
1998 · WENDY L. ADAMS, THOMAS V. JONES · Addiction Biology · 11
SAT0243 Incidence of thromboembolic events in the tofacitinib rheumatoid arthritis, psoriasis, psoriatic arthritis and ulcerative colitis development programmes
2018 · P.J. Mease, J. Kremer, et al. · Annals of the Rheumatic Diseases · 9
PDF
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs
2022 · Kevin L. Winthrop, Arne Yndestad, et al. · Rheumatology and Therapy · 8
PDF
Works count: 55
Citation count: 1,824
H-index: 18
I10-index: 23
Year
Topic
Type